Aplagon, a clinical stage biopharmaceutical company developing a first-in-class therapeutic for thrombo-inflammatory diseases, known as APAC, a heparin proteoglycan mimetic with antiplatelet and ...
Finally, the issuing pathologist has changed his position 180 degrees. It’s consistent with what the Greenbergs have been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback